Development of a novel cell-based assay to monitor the transactivation activity of the HSV-1 protein ICP0.

Antiviral Res

Department of Molecular Biosciences, University of Kansas, Lawrence, KS 66045, United States. Electronic address:

Published: August 2015

The herpes simplex virus type 1 (HSV-1) immediate-early phosphoprotein infected cell protein 0 (ICP0) is a potent transcriptional activator of viral genes and is required for efficient viral replication and reactivation from latency. However, it is largely unknown what role specific cellular factors play in the transactivator function of ICP0. With the long-term goal of identifying these factors, we developed a cell-based assay in a 96-well format to measure this activity of ICP0. We designed a system using a set of HSV-1 GFP reporter viruses in which the expression of GFP is potently induced by ICP0 in cell culture. The initial feasibility of this system was confirmed over a 24-h period by fluorescence microscopy. We adapted this assay to a 96-well plate format, quantifying GFP expression with a fluorescence scanner. Our results indicate that the cell-based assay we developed is a valid and effective method for examining the transactivating activity of ICP0. This assay can be used to identify cellular factors that regulate the transactivating activity of ICP0.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492837PMC
http://dx.doi.org/10.1016/j.antiviral.2015.04.012DOI Listing

Publication Analysis

Top Keywords

cell-based assay
12
activity icp0
12
protein icp0
8
cellular factors
8
assay 96-well
8
transactivating activity
8
icp0
7
assay
5
development novel
4
novel cell-based
4

Similar Publications

Induced pluripotent stem cell (iPSC)-derived natural killer (NK) cells offer an opportunity for a standardized, off-the-shelf treatment with the potential to treat a wider population of acute myeloid leukaemia (AML) patients than the current standard of care. FT538 iPSC-NKs express a high-affinity, noncleavable CD16 to maximize antibody dependent cellular cytotoxicity, a CD38 knockout to improve metabolic fitness, and an IL-15/IL-15 receptor fusion preventing the need for cytokine administration, the main source of adverse effects in NK cell-based therapies. Here, we sought to evaluate the potential of FT538 iPSC-NKs as a therapy for AML through their effect on AML cell lines and primary AML cells.

View Article and Find Full Text PDF

This scoping review aims to understand the cell-based meat production process, including the regulations, potential hazards, and critical points of this production. This review includes studies on cultured meat production processes, health hazards, and regulatory guidelines, excluding those without hazard analysis, incomplete texts, or studies published before 2013. The search was performed in eight electronic databases (MEDLINE, Web of Science, Embase, Cochrane Library, Scopus, LILACS, and Google Scholar) using MeSH terms and adaptations for each database.

View Article and Find Full Text PDF

3D bioprinting approaches for enhancing stem cell-based neural tissue regeneration.

Acta Biomater

January 2025

Department of Chemistry and Chemical Biology, Rutgers, The State University of New Jersey, 123 Bevier Road, Piscataway, NJ 08854, USA. Electronic address:

Article Synopsis
  • 3D bioprinting shows great potential for enhancing stem cell research and creating new therapies in neural tissue engineering and disease modeling.
  • Recent advancements in this technology are examined, including the advantages and limitations of different printing methods, the selection of bioink materials for stem cells, and the use of nanomaterials to improve outcomes.
  • The paper also introduces 4D bioprinting and discusses its potential to create time-responsive constructs that enhance the integration and function of bioprinted neural tissues, which could significantly impact regenerative medicine.
View Article and Find Full Text PDF

Huntington's disease (HD) is an inherited neurodegenerative disease characterized by uncontrolled movements, emotional disturbances, and progressive cognitive impairment. It is estimated to affect 4.3 to 10.

View Article and Find Full Text PDF

Aim Traditional Ayurvedic herbo-mineral medicines have proven their potential in managing COVID-19. Cell-based assays of the Svarnvir-IV tablet demonstrated the virucidal activity against SARS-CoV-2 and its therapeutic action, along with safety in cytotoxicity, has been proved. In the present study, in vivo, safety profile and compositional analysis of the Svarnvir-IV tablet were performed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!